Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by GrahamBon Sep 19, 2023 7:32pm
60 Views
Post# 35644413

RE:RE:GE HealthCare gets $44 mln grant to develop AI-assisted ultr

RE:RE:GE HealthCare gets $44 mln grant to develop AI-assisted ultr

MartyD wrote: That's actually another cryptic news story.  You don't really think ASCEND would enter a corroboration with VPT to the extent they claim without an "option to buy/merge" do you?  Obviously, this has left GEHC out on the street so now they have to get a grant to develope AI in ultrasound.  Since Welch ruined GE, nothing has gone right for them.  I suspect of the 44 mLn,  half will go into corporate coffers as administrative costs, the other half will be used to try to catch and get ahead of VPT. It's like a yacht race, the lead yacht has the race under control. To pass another yacht needs to take some chance and hope it pays off.

 

Really Marty
"You don't really think ASCEND would enter a corroboration with VPT to the extent they claim without an "option to buy/merge" do you?  "
 

I have read all the documents associated with this news and can't find this important quote

wase provide the link for the "cryptic" quote 

 

<< Previous
Bullboard Posts
Next >>